{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:22:33Z","timestamp":1788549753805,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T00:00:00Z","timestamp":1602288000000},"content-version":"vor","delay-in-days":2839,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1194\/jlr.m031344","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T19:16:23Z","timestamp":1351538183000},"page":"177-188","source":"Crossref","is-referenced-by-count":10,"title":["Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis"],"prefix":"10.1016","volume":"54","author":[{"given":"Alison M.","family":"Strack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Carballo-Jane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley Ann","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Thankappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Kawka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Mariano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Menke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvi","family":"Luell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel I.","family":"Zycband","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Raubertas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl P.","family":"Sparrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Gerard","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Sitlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M031344_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/j.1875-9114.1988.tb04085.x","article-title":"Nicotinic acid: a review of its clinical use in the treatment of lipid disorders","volume":"8","author":"Figge","year":"1988","journal-title":"Pharmacotherapy."},{"key":"10.1194\/jlr.M031344_bib2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1592\/phco.21.6.576.34541","article-title":"Poor adherence with hypolipidemic drugs: a lost opportunity","volume":"21","author":"Tsuyuki","year":"2001","journal-title":"Pharmacotherapy."},{"key":"10.1194\/jlr.M031344_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-6980(89)90088-9","article-title":"Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid","volume":"38","author":"Morrow","year":"1989","journal-title":"Prostaglandins."},{"key":"10.1194\/jlr.M031344_bib4","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12499963","article-title":"Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans","volume":"98","author":"Morrow","year":"1992","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.M031344_bib5","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1124\/mol.106.030833","article-title":"Nicotinic acid-induced flushing is mediated by activation of epidermal Langerhans cells","volume":"70","author":"Beny\u00f3","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1194\/jlr.M031344_bib7","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1038\/sj.jid.5700586","article-title":"Langerhans cells release prostaglandin D2 in response to nicotinic acid","volume":"126","author":"Maciejewski-Lenoir","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1194\/jlr.M031344_bib8","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.0601574103","article-title":"Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M031344_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/sj.clpt.6100180","article-title":"Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1","volume":"81","author":"Lai","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1194\/jlr.M031344_bib10","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1172\/JCI42273","article-title":"Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice","volume":"120","author":"Hanson","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M031344_bib11","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/ATVBAHA.108.171363","article-title":"Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice","volume":"28","author":"van der Hoorn","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M031344_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0021-9150(78)90010-2","article-title":"Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs","volume":"29","author":"Lundholm","year":"1978","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.M031344_bib13","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.ATV.20.7.1724","article-title":"The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis","volume":"20","author":"Cayatte","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M031344_bib16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.bbrc.2006.10.121","article-title":"Protection of atherogenesis in thromboxane A2 receptor-deficient mice is not associated with thromboxane A2 receptor in bone marrow-derived cells","volume":"351","author":"Zhuge","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.M031344_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1388-1981(99)00164-X","article-title":"The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs","volume":"1483","author":"Abramovitz","year":"2000","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M031344_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1006\/abio.2000.4698","article-title":"A reporter gene assay for high-throughput screening of G-protein-coupled receptors stably or transiently expressed in HEK293 EBNA cells grown in suspension culture","volume":"284","author":"Durocher","year":"2000","journal-title":"Anal. Biochem."},{"key":"10.1194\/jlr.M031344_bib19","doi-asserted-by":"crossref","first-page":"30725","DOI":"10.1074\/jbc.M301838200","article-title":"Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases","volume":"278","author":"Li","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M031344_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/01.ATV.21.1.115","article-title":"Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering","volume":"21","author":"Sparrow","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M031344_bib21","doi-asserted-by":"crossref","first-page":"U11","DOI":"10.1097\/00041433-199702000-00018","article-title":"Atherosclerosis: cell biology and lipoproteins","volume":"8","author":"Daugherty","year":"1997","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.M031344_bib22","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI59262","article-title":"Niacin and biosynthesis of PGD(2)by platelet COX-1 in mice and humans","volume":"122","author":"Song","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M031344_bib23","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/ATVBAHA.107.142570","article-title":"Mouse models for atherosclerosis and pharmaceutical modifiers","volume":"27","author":"Zadelaar","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M031344_bib24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/138945008783755575","article-title":"Progression and disruption of advanced atherosclerotic plaques in murine models","volume":"9","author":"Rosenfeld","year":"2008","journal-title":"Curr. Drug Targets."},{"key":"10.1194\/jlr.M031344_bib25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/138161208783497769","article-title":"Apolipoprotein E knockout models","volume":"14","author":"Kolovou","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1194\/jlr.M031344_bib26","first-page":"79","article-title":"Comparison of simvastatin and nicotinic acid administration in alcohol-treated Wistar rats","volume":"49","author":"Kolovou","year":"2008","journal-title":"Hellenic J. Cardiol."},{"key":"10.1194\/jlr.M031344_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0021-9150(88)90104-9","article-title":"Effects of fenofibrate, gemfibrozil and nicotinic acid on plasma lipoprotein levels in normal and hyperlipidemic mice. A proposed model for drug screening","volume":"70","author":"Olivier","year":"1988","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.M031344_bib28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.RES.5.6.617","article-title":"Effects of nicotinic acid on serum and tissue cholesterol in rabbits","volume":"5","author":"Merrill","year":"1957","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.M031344_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.fjc.0000162764.12309.25","article-title":"Paradoxical effects of fenofibrate and nicotinic acid in apo E-deficient mice","volume":"46","author":"Declercq","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1194\/jlr.M031344_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell."},{"key":"10.1194\/jlr.M031344_bib31","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.bbrc.2007.02.079","article-title":"Critical role of cholesterol ester transfer protein in nicotinic acid-mediated HDL elevation in mice","volume":"355","author":"Hernandez","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.M031344_bib32","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.clpt.6100345","article-title":"Pharmacokinetics, pharmacodynamics, and safety of a prostaglandin D2 receptor antagonist","volume":"83","author":"Lai","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1194\/jlr.M031344_bib34","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1177\/0091270009339593","article-title":"Laropiprant in combination with extended-release niacin does not alter urine 11-dehydrothromboxane B2, a marker of in vivo platelet function, in healthy, hypercholesterolemic, and diabetic subjects","volume":"49","author":"Lauring","year":"2009","journal-title":"J. Clin. Pharmacol."},{"key":"10.1194\/jlr.M031344_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ajh.2830190103","article-title":"Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease","volume":"19","author":"Fitscha","year":"1985","journal-title":"Am. J. Hematol."},{"key":"10.1194\/jlr.M031344_bib37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0262-1746(82)80017-6","article-title":"Hypertension and beneficial treatment with beta-blocking agents does not change the platelet sensitivity to the antiaggregatory prostaglandins","volume":"9","author":"Sinzinger","year":"1982","journal-title":"Prostaglandins Leukot. Med."},{"key":"10.1194\/jlr.M031344_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003877","article-title":"Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression","volume":"4","author":"Lauring","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1194\/jlr.M031344_bib39","unstructured":"HPS-2 THRIVE. Available at: http:\/\/www.ctsu.ox.ac.uk\/~thrive. 2012. 8-14-2012."},{"key":"10.1194\/jlr.M031344_bib40","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M031344_bib41","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1016\/j.bmcl.2010.10.018","article-title":"Potent and highly selective DP1 antagonists with 2,3,4,9-tetrahydro-1H-carbazole as pharmacophore","volume":"20","author":"Li","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1194\/jlr.M031344_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00011-007-6167-6","article-title":"Potential role for epidermal Langerhans cells in nicotinic acid-induced vasodilatation in the mouse","volume":"56","author":"Carballo-Jane","year":"2007","journal-title":"Inflamm. Res."},{"key":"10.1194\/jlr.M031344_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1161\/01.CIR.0000153386.95356.78","article-title":"Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism","volume":"111","author":"Egan","year":"2005","journal-title":"Circulation."},{"key":"10.1194\/jlr.M031344_bib15","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1172\/JCI200421446","article-title":"Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice","volume":"114","author":"Kobayashi","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M031344_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/09537100903521611","article-title":"Effects of extended release niacin\/laropiprant, laropiprant, extended release niacin and placebo on platelet aggregation and bleeding time in healthy subjects","volume":"21","author":"Lai","year":"2010","journal-title":"Platelets."},{"key":"10.1194\/jlr.M031344_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0161-4630(81)90056-2","article-title":"Value of platelet sensitivity to antiaggregatory prostaglandins (PGI2, PGE1, PGD2) in 50 patients with myocardial infarction at young age","volume":"7","author":"Sinzinger","year":"1981","journal-title":"Prostaglandins Med."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520417729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520417729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M031344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T22:44:36Z","timestamp":1637448276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520417729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0022227520417729"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m031344","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}